Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nightingale HealthNGHLF 67 EV-to-EBIT is -0.74 as of Aug. 04, 2026. GuruFocus rates NGHLF with a GF Score™ of 67/100 and a GF Value™ of $4.61. The stock has 6 warning signs investors should review. Among 470 Healthcare Providers & Services companies, Nightingale Health ranks worse than 212765.74% on this metric.
Nightingale Health (OTCPK:NGHLF) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Nightingale Health's Enterprise Value for the quarter that ended in Dec. 2025 was $61.22 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nightingale Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $-20.85 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nightingale Health EV-to-EBIT Related Terms
Nightingale Health EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Nightingale Health's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Nightingale Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nightingale Health EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nightingale Health's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Nightingale Health's EV-to-EBIT falls into.
Nightingale Health's current Enterprise Value is $15.45 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Nightingale Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $-20.85 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nightingale Health (NGHLF) has a EV-to-EBIT of -0.74 as of Aug. 04, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Nightingale Health and its competitors. According to the industry distribution chart, Nightingale Health ranks #999999 out of 470 companies in the Healthcare Providers & Services industry.
Is Nightingale Health's EV-to-EBIT too high?
Nightingale Health's current EV-to-EBIT is -0.74. Based on the distribution chart, Nightingale Health ranks #999999 out of 470 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Nightingale Health has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Nightingale Health's EV-to-EBIT compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Nightingale Health ranks #999999 out of 470 companies for EV-to-EBIT. This places Nightingale Health in the lower half of its industry. The industry median EV-to-EBIT is 16.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 16.03, based on 470 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Nightingale Health and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 16.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nightingale Health's current EV-to-EBIT is -0.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nightingale Health stock overvalued right now?
Nightingale Health (NGHLF) has a current EV-to-EBIT of -0.74. The stock's GF Value™ is $4.61, compared to a current price of $1.19 — trading 74.2% below its estimated fair value. The current EV-to-EBIT is -0.74. Nightingale Health's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Nightingale Health (NGHLF), the current EV-to-EBIT is -0.74 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nightingale Health (NGHLF) Overvalued in 2026?
Based on GuruFocus' analysis, Nightingale Health stock appears to be undervalued.
The current stock price of $1.19 is trading 74.2% below its estimated GF Value™ of $4.61.
Key valuation signals for NGHLF:
EV-to-EBIT: -0.74
GF Value™: $4.61 vs. price of $1.19 (74.2% below fair value)
No single metric tells the full story. See the NGHLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nightingale Health PLC offers a health data platform that detects disease risks. The Health Data Platform empowers individuals to take actions to prevent diseases by allowing them access to disease risk information. With its Health Data Platform, the company connects the services of healthcare actors with the preventative health needs of individuals. The company operates in Finland, Japan, the United Kingdom, Singapore, and the USA.
67GF Score
Get the complete analysis for NGHLF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGHLF has been successfully added to your 
